Depression Clinical Trials in Houston, Texas

9 studies are recruiting for depression in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story

   The main goal of this research is to help families who are experiencing food insecurity (FI) and help mothers with depression. The next goal is to provide other resources to help with household needs like rent or utility assistance, health insurance, anxiety, and depression. Our theory is that help…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Texas Children's Hospital, Houston, Texas

   Run by

   Baylor College of Medicine

   See if you can join NCT05809115 on ClinicalTrials.gov

2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   Brain Health Consultants and TMS Center, Houston, Texas

   Locations

   69 in total

   Run by

   Cybin IRL Limited

   See if you can join NCT06793397 on ClinicalTrials.gov

3. Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

   In a sample of patients already receiving ketamine (or esketamine) treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend (es)ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive training protocol. Thi…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Baylor College of Medicine, Houston, Texas

   Locations

   3 in total

   Run by

   University of Pittsburgh

   See if you can join NCT06526078 on ClinicalTrials.gov

4. TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

   This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   The University of Texas M. D. Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT06801041 on ClinicalTrials.gov

5. Telehealth Behavioral Activation for Teens

   Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g.…

   Stage

   Not phased

   Ages

   12 to 18

   Site

   Baylor College of Medicine, Houston, Texas

   Run by

   Baylor College of Medicine

   See if you can join NCT06273995 on ClinicalTrials.gov

6. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

   Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of dep…

   Stage

   Phase 3

   Ages

   10 to 17

   Site

   Kaleidoscope Clinical Research /ID# 277650, Houston, Texas

   Locations

   81 in total

   Run by

   AbbVie

   See if you can join NCT04777357 on ClinicalTrials.gov

7. Intracranial Investigation of Neural Circuity Underlying Human Mood

   Depression is one of the most common disorders of mental health, affecting 7-8% of the population and causing tremendous disability to afflicted individuals and economic burden to society. In order to optimize existing treatments and develop improved ones, the investigators need a deeper understand…

   Stage

   Not phased

   Ages

   21 to 70

   Site

   Baylor College of Medicine, Houston, Texas

   Run by

   Baylor College of Medicine

   See if you can join NCT05871372 on ClinicalTrials.gov

8. Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

   To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this st…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   MD Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT05474846 on ClinicalTrials.gov

9. Functional Connectivity Alterations in Suicidal Patients Among Opioid Users

   Suicide is the 10th leading cause of death for Americans of all ages and more people in the United States now die from suicide than die from car accidents. Although death by firearm remains the most common cause of suicide in the United States, an intentional overdose of substance usage such as pre…

   Stage

   Not phased

   Ages

   18 to 64

   Site

   The Menninger Clinic, Houston, Texas

   Run by

   Baylor College of Medicine

   See if you can join NCT05489042 on ClinicalTrials.gov